Ignite Creation Date:
2024-05-06 @ 8:58 AM
Last Modification Date:
2024-10-26 @ 12:07 PM
Study NCT ID:
NCT02867891
Status:
COMPLETED
Last Update Posted:
2017-01-18
First Post:
2016-08-10
Brief Title:
Sorafenib In Relapse of FMS-like Tyrosine Kinase 3 FLT3-Internal Tandem Duplication ITD AML Trial
Sponsor:
Robert Zeiser
Organization:
University of Freiburg
Organization Data
Organization:
University of Freiburg
Class:
OTHER
Study ID:
SIRA
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Robert Zeiser
Lead Sponsor Class:
OTHER
Responsible Party:
Robert Zeiser
Responsible Party Title:
Head of Tumor Imunnology and Immun regulation
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of Freiburg
Old Name:
None
Old Organization:
None